
BioGovernance Commons and China’s Role in Global Risk Governance
4 contributors - Hardback
£119.99
Ruipeng Lei is Professor, Vice Dean of the Advanced Institute of Humanities and Social Sciences, and Director of the Center for Ethics and Governance of Science and Technology at the University of Electronic Science and Technology of China (UESTC). She co-founded the Research Center for Bioethics at Huazhong University of Science and Technology in Wuhan in 2002 and served as its Executive Director until 2022. Her research focuses on the ethical and governance challenges posed by emerging technologies, including synthetic biology, xenotransplantation, human genome editing, neurotechnology, artificial intelligence, and robotics. She has published more than 100 research articles, reviews, and commentaries and has authored or edited ten books in Chinese and English. In 2019, she was the first author of the Nature commentary ‘Reboot Ethics Governance in China.’ She completed a National Key R&D project (2019-2024) and currently leads two national key projects as principal investigator on synthetic biology, biobanks, and biomedical and health data. Her international service includes work with The Hastings Center, the WHO Ethics and COVID-19 Working Group, and the UNESCO Working Group on the Draft Recommendation on the Ethics of Neurotechnologies.